Anti-Hexokinase II抗体[3D3] (ab104836)

发表研究结果有使用 ab104836?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab104836 被引用在 7 文献中.

  • Li Y  et al. Mitochondrial pyruvate carrier function is negatively linked to Warburg phenotype in vitro and malignant features in esophageal squamous cell carcinomas. Oncotarget 8:1058-1073 (2017). WB . PubMed: 27911865
  • Yang HJ  et al. Expression of Glut-1 and HK-II in Pancreatic Cancer and Their Impact on Prognosis and FDG Accumulation. Transl Oncol 9:583-591 (2016). PubMed: 27916293
  • Li Y  et al. PDHA1 gene knockout in prostate cancer cells results in metabolic reprogramming towards greater glutamine dependence. Oncotarget 7:53837-53852 (2016). PubMed: 27462778
  • Pertega-Gomes N  et al. A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy. J Pathol 236:517-30 (2015). IHC ; Human . PubMed: 25875424
  • Yao M  et al. Dicer mediating the expression of miR-143 and miR-155 regulates hexokinase II associated cellular response to hypoxia. Am J Physiol Lung Cell Mol Physiol 307:L829-37 (2014). PubMed: 25172909
  • Kim HM  et al. Site-specific metabolic phenotypes in metastatic breast cancer. J Transl Med 12:354 (2014). PubMed: 25496516
  • Chang HT  et al. Ketolytic and glycolytic enzymatic expression profiles in malignant gliomas: implication for ketogenic diet therapy. Nutr Metab (Lond) 10:47 (2013). IHC . PubMed: 23829383

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

注册